Search

everythinglearnresearchcommunity

for

Search:↓

The guideline emphasizes a multidisciplinary approach and informed consent for gender-affirming hormone treatment, with regular follow-ups and individualized care.

Early diagnosis and personalized treatment are crucial for managing PCOS and preventing complications.

Metformin lowers prolactin in women without PCOS but not in those with PCOS, where it reduces other hormones instead.

Tirzepatide might help manage PCOS in obese patients but needs more research to confirm safety and effectiveness.

Nanotechnology improves Clomiphene citrate's effectiveness and reduces side effects for treating ovulatory disorders.

Certain supplements, like whey protein isolate and growth hormones, can worsen hair loss.

Polycystic Ovary Syndrome (PCOS) affects 6%-15% of women of reproductive age, causing symptoms like acne and hair loss, and increasing the risk of type 2 diabetes and heart disease; it's managed through diet, exercise, and medications like Metformin and hormonal contraceptives.

Targeted anticancer therapies can cause severe side effects similar to traditional chemotherapy, but with different types.

The study concluded that similar pathways regulate hair growth in dogs and mice, and these pathways are disrupted in dogs with Alopecia X, affecting stem cells and hormone metabolism.

High androgen levels in postmenopausal women may suggest an ovarian tumor, and removing it can improve heart and metabolic health.

A woman's rare benign tumor that released both cortisol and testosterone was successfully removed, improving her health.

Women with PCOS often experience depression and anxiety, affecting their quality of life.

The document concludes that a systematic approach is crucial to identify causes of androgen excess in women beyond the most common cause, Polycystic ovary syndrome (PCOS).

The guideline provides healthcare professionals in South Africa with instructions for comprehensive, multidisciplinary gender-affirming care, including HIV prevention and treatment for transgender and gender diverse individuals.

Evaluate and manage androgen excess in women with a systematic approach, considering both physical and psychological impacts.

The conclusion is that obesity should be managed with a slow, balanced approach to diet and exercise, with medication and surgery as additional options, and education and access to care are important.

PCOS involves immune system issues and inflammation, possibly leading to autoimmune diseases.

Androgenetic alopecia is a common hair loss condition influenced by various factors and linked to psychosocial and cardiovascular issues.

Lipid Accumulation Product and Free Androgens Index are effective for assessing fatty liver disease risk in women with Polycystic Ovary Syndrome.

Spironolactone and metformin work similarly for PCOS symptoms, but more research is needed.

The document summarizes medical findings on topics like heart rhythm treatment, sleep apnea therapy, and various health conditions and treatments.

A woman with acne and baldness was found to have a rare ovarian condition but successfully had a child through fertility treatment.

The conclusion is that endocrinology significantly impacts medicine with various common medications used for treatment.

Mutations in the androgen receptor gene cause different levels of androgen insensitivity, making it hard to create simple tests for the condition.

Two teenage brothers had a rare, treatment-resistant form of female-pattern hair loss with unusual scalp changes.

Early menarche may indicate higher risk of severe hirsutism in PCOS patients.

Oestrogens are key for bone growth during puberty in both boys and girls.

Low-dose glucocorticoid treatment improves pregnancy and birth rates in women with nonclassical 21-hydroxylase deficiency.

Formestane is a preferred second-line treatment for advanced breast cancer in postmenopausal women because it's effective and has fewer side effects.

High androgen levels in young women with PCOS are linked to higher blood pressure.